SEARCH

SEARCH BY CITATION

References

  • Allan, D., Limbrick, A., Thomas, P., Westerman, M. (1981) Microvesicles from sickle erythrocytes and their relation to irreversible sickling. British Journal of Haematology, 47, 383390.
  • Beurling-Harbury, C. & Schade, S. (1989) Platelet activation during crisis in sickle cell anemia patients. American Journal of Hematology, 31, 237241.
  • Brittain, H., Eckman, J., Swerlick, R., Howard, R., Wick, T. (1993) Thrombospondin from activated platelets promotes sickle cell erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood, 81, 21372143.
  • Browne, P., Mosher, D., Steinberg, M., Hebbel, R. (1996) Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. American Journal of Hematology, 51, 296301.DOI: 10.1002/(sici)1096-8652(199604)51:4<296::aid-ajh8>3.0.co;2-r
  • Feelisch, M. & Stamler, J. (1996) Donors of nitrogen oxides. In: Methods in Nitric Oxide Research (ed. by M.Feelisch & J. Stamler), pp. 5–115. John Wiley and Sons, New York.
  • Ferranti, P., Malorni, A., Mamone, G., Sannolo, N., Marino, G. (1997) Characterisation of S-nitrosohaemoglobin by mass spectrometry. FEBS Letters, 400, 1924.DOI: 10.1016/s0014-5793(96)01258-6
  • Fukuto, J., Chiang, K., Hszieh, R., Wong, P., Chaudhuri, G. (1992) The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. Journal of Pharmacology and Experimental Therapeutics, 263, 546551.
  • Gladwin, M., Schechter, A., Shelhamer, J., Pannel, L., Conway, D., Hrinczenko, B., Nichols, J., Pease-Fye, M., Noguchi, C., Rodgers, G., Ognibene, F. (1999) Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. Journal of Clinical Investigation, 104, 937945.
  • Head, C., Brugnara, C., Martinez-Ruiz, R., Kacmarek, R., Bridges, K., Kuter, D., Block, K., Zapol, W. (1997) Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. Journal of Clinical Investigation, 100, 11931198.
  • Hrinczenko, B., Alayash, A., Wink, D., Gladwin, M., Rodgers, G., Schechter, A. (2000a) Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport. British Journal of Haematology, 110, 19.DOI: 10.1046/j.1365-2141.2000.02272.x
  • Hrinczenko, B., Schechter, A., Wojtkowski, T., Pannell, L., Cashon, R., Alayash, A. (2000b) Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes. Biochemical Biophysical Research Communications, 275, 962967.
  • Ignarro, L., Lippton, H., Edwards, J., Baricos, W., Hyman, A., Kadowitz, P., Gruetter, C. (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. Journal of Pharmacology and Experimental Therapeutics, 218, 739749.
  • Keh, D., Gerlach, M., Kurer, I., Seiler, S., Kerner, T., Falke, K., Gerlach, H. (1996) The effects of nitirc oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin. Blood Coagulation and Fibrinolysis, 7, 615624.
  • Kon, K., Maeda, N., Shiga, T. (1977) Effect of nitric oxide on the oxygen transport of human erythrocytes. Journal of Toxicology in Environmental Health, 2, 11091113.
  • Kuranstin-Mills, J., Ibe, B., Raj, J., Siegel, R., Lessin, L. (1994) Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. British Journal of Haematology, 87, 580585.
  • Kuypers, F., Van Den Berg, J., Lubin, B. (1994) Membrane lipids and vesiculation. In: Sickle Cell Disease: Basic Principles and Clinical Practice (ed. by S.Embury, R.Hebbel, N.Nohandas & M. Steinberg), pp. 139–150. Raven Press, New York.
  • Lopez, B., Barnett, J., Ballas, S., Christopher, T., Davis-Moon, L., Ma, X. (1996) Nitric oxide metabolite levels in acute vaso-occlusive sickel cell crisis. Academic Emergency Medicine, 3, 10981103.
  • Mehta, P. & Mehta, J. (1980) Abnormalities of platelet aggregation in sickle cell disease. Journal of Pediatrics, 96, 209213.
  • Morley, D., Maragos, C., Zhang, X.-Y., Boignon, M., Wink, D., Keefer, L. (1993) Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. Journal of Cardiovascular Pharmacology, 21, 670676.
  • Phillips, D., Charo, I., Parise, L., Fitzgerald, L. (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood, 71, 831842.
  • Pino, R. & Feelisch, M. (1994) Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using l-cysteine. Biochemical Biophysical Research Communications, 201, 5462.
  • Radomski, M., Palmer, R., Moncada, S. (1987) Comparative pharmacology of endothelial-derived relacing factor, nitric oxide and prostacyclin in platelets. British Journal of Pharmacology, 92, 181187.
  • Rees, D., Cervi, P., Grimwade, D., O'Driscoll, A., Hamilton, M., Parker, N., Porter, J. (1995) The metabolites of nitric oxide in sickle cell disease. British Journal of Haematology, 91, 834837.
  • Rink, T. & Sage, S. (1990) Calcium signaling in human platelets. Annual Review of Physiology, 52, 431449.
  • Samama, C., Diaby, M., Fellahi, J., Mdhafar, A., Eryaud, D., Arock, M., Guillosson, J., Coriat, P., Rouby, J. (1995) Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology, 83, 5665.
  • Shattil, S.J., Hoxie, J.A., Cunningham, M., Brass, L.F. (1985) Changes in the platelet membrane glycoprotein IIb-IIIa complex during activation. Journal of Biological Chemistry, 260, 1110711114.
  • Shattil, S., Cunningham, M., Hoxie, J. (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 70, 307315.
  • Space, S., Lane, P., Pickett, C., Weil, J. (2000) Nitric oxide attenuates normal and sickle red blood cell adherenece to pulmonary endothelium. American Journal of Hematology, 63, 200204.DOI: 10.1002/(sici)1096-8652(200004)63:4<200::aid-ajh7>3.0.co;2-q
  • Stamler, J. (1995) S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Current Topics in Microbiology and Immunology, 196, 1936.
  • Vanderford, P., Wong, J., Chang, R., Keefer, L., Soifer, S., Fineman, J. (1994) Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs. Journal of Cardiovascular Pharmacology, 23, 113119.
  • Wun, T., Paglieroni, T., Rangaswami, A., Franklin, P., Welborn, J., Cheung, A., Tablin, F. (1998) Platelet activation in patients with sickle cell disease. British Journal of Haematology, 100, 741749.DOI: 10.1046/j.1365-2141.1998.00627.x